Search Results

An image of the building of the headquarters of WHO.
MBT Desk
2 min read
WHO expands access by including immunotherapies and GLP-1 agonists in its EML for broader global health equity.
A recent study in GLP-1 drugs potentially improved surgical complications and recovery in diabetes patients (Representational Image: Pexels)
Dr. Disha Merlyn Mathias
3 min read
A possibility for improving surgical complications in diabetic patients
Bariatric surgery found to be more effective than GLP-1 drugs in reducing kidney disease progression, according to a recent study. (Representational image: Wikimedia Commons)
Ankur Deka
3 min read
Study finds bariatric surgery significantly reduces risk of chronic kidney disease progression compared to GLP-1 drugs in patients with obesity and diabetes
After extensive review, the MHRA concludes no link between popular diabetes drugs like Wegovy and mental health concerns. (Wikimedia Commons)
Ankur Deka
2 min read
MHRA concludes there is no evidence to support a connection between GLP-1 receptor agonists, including Novo Nordisk's Wegovy, and suicide-related risks
Several GLP-1 receptor agonists are available on the market, including exenatide (Byetta), liraglutide (Victoza), dulaglutide (Trulicity), and semaglutide (Ozempic). (Representational Image: Unsplash)
MBT Desk
4 min read
Explore the side effects of GLP-1 drugs, used for managing type 2 diabetes, including gastrointestinal issues, hypoglycemia, pancreatitis, and more
With the skyrocketing popularity of weight-loss drugs like Ozempic, Wegovy, and Mounjaro, health experts are noticing an increasing trend of use among younger Americans. 
(Representational Image: Pixabay)
MBT Desk
3 min read
Parents Should be more Careful : Insights from Doctors on Youthful Usage of these Drugs and Health Risks
Read More
logo
Medbound Times
www.medboundtimes.com